cost effectiveness of ‘on demand’ hiv pre-exposure prophylaxis for non-injection drug-using men who have sex with men in canada
Clicks: 196
ID: 227494
2015
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
BACKGROUND: Recent trials report the efficacy of continuous tenofovir-based pre-exposure prophylaxis (PrEP) for prevention of HIV infection. The cost effectiveness of ‘on demand’ PrEP for non-injection drug-using men who have sex with men at high risk of HIV acquisition has not been evaluated.
| Reference Key |
ouellet2015canadiancost
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Estelle Ouellet;Madeleine Durand;Jason R Guertin;Jacques LeLorier;Cécile L Tremblay |
| Journal | zdravstveno varstvo |
| Year | 2015 |
| DOI | 10.1155/2015/964512 |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.